Filtered By:
Vaccination: AIDS Vaccine

This page shows you your search results in order of relevance. This is page number 7.

Order by Relevance | Date

Total 480 results found since Jan 2013.

Flu, COVID - 19 Vaccination Cover High Among Health Care Personnel
HCP who reported employer vaccination requirements had higher vaccination coverage for flu, COVID - 19 primary series, COVID - 19 booster
Source: The Doctors Lounge - Oncology - October 25, 2022 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

FDA Oversight of Clinical Trials Described as ‘ Grossly Inadequate ’
Article describes inadequate oversight relating to development of COVID - 19 vaccines and predating the pandemic
Source: The Doctors Lounge - Oncology - November 17, 2022 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Brigitte Askonas obituary
Immunologist whose work led to the development of many new vaccinesBrigitte Askonas, widely known as Ita, who has died aged 89, was one of the leading figures of modern immunology. She built on the work of the science's earlier pioneers, Louis Pasteur and Paul Ehrlich, by increasing understanding of the immune system as an intricate network of many cell types interacting and producing mediators to control their complex functions.The principal base for her work was the National Institute for Medical Research (NIMR), north-west London, which she joined in 1952. She spent 36 years there, the last 12 of them as head of the imm...
Source: Guardian Unlimited Science - January 10, 2013 Category: Science Authors: Bridget Ogilvie Tags: The Guardian Obituaries Medical research Immunology Biochemistry and molecular biology Science Source Type: news

Clinical round-up
Huge burden of undiagnosed gonorrhoea and Chlamydia due to sole testing of urogenital sites While routine multi-site testing for gonorrhoea and Chlamydia in men who have sex with men (MSM) is increasingly becoming the standard of care, the same is not true for heterosexual women who may also practice oral and anal sexual intercourse. A group of Dutch investigators have reported a study exploring the number of missed infections if only the urogenital site was tested using nucleic acid amplification tests.1 Sampling of the urogenital site was considered to be urine or swabs taken from the urethra, vagina or cervix. A missed ...
Source: Sexually Transmitted Infections - January 21, 2013 Category: Sexual Medicine Authors: Desai, M. Tags: Liver disease, Drugs: infectious diseases, Hepatitis and other GI infections, HIV/AIDS, Vaccination / immunisation, Reproductive medicine, Ophthalmology, Respiratory medicine, Hepatitis (sexual health), HIV / AIDS, Chlamydia, Gonorrhoea, HIV infections, O Source Type: research

Novel and emerging therapies safeguarding health of humans and their companion animals: a review.
Abstract Modern medicine has helped to a great extent to eradicate and cure several diseases of mankind and animals. But the existence of incurable diseases like cancer, Acquired Immunodeficiency Syndrome (AIDS), diabetes or rheumatoid arthritis, side effects of allopathic medicine, increasing trend of antibiotic resistance and chemicals and biopesticides causing dietary risk have made the situation more critical than ever before. Thus, it has become a matter of concern for the scientists and researchers to develop novel therapies. Bacteriophage therapy to treat pathogenic bacterial infections, virophage therapy f...
Source: Pakistan Journal of Biological Sciences: PJBS - February 1, 2013 Category: Biomedical Science Authors: Dhama K, Chakraborty S, Mahima, Wani MY, Verma AK, Deb R, Tiwari R, Kapoor S Tags: Pak J Biol Sci Source Type: research

Preventing HIV: the latest on vaccine development and gene therapy
Robin Shattock, of Imperial College London, explains what new research might mean for HIV control in the developing worldThere has been a development in HIV prevention and treatment. What's happened?Two groups in the US [the Aaron Diamond Aids research centre and the Centre for disease control and prevention] have shown that injection of long-acting HIV drugs could completely prevent infection of monkeys. This is significant because, if it works in humans, it might be possible to get a shot in the arm every three months to protect yourself against HIV. The same technology could be used to treat those already infected with ...
Source: Guardian Unlimited Science - March 10, 2014 Category: Science Authors: Anna Scott Tags: Global health Global health innovation Guardian Professional Genetics Medical research Vaccines and immunisation Technology Q & amp;As Aids and HIV Global development professionals network Interviews Imperial College London Source Type: news

Learning from past HIV vaccine trials
A multi-national research team led by Duke Medicine scientists has identified a subclass of antibodies associated with an effective immune response to an HIV vaccine.The finding, reported in the journal Science Translational Medicine, helps explain why a combination of two vaccines was able to show some effect, when one vaccine alone did not. The study also provides key insights that could aid development of new vaccines."More is not always better with an antibody response," said senior author Georgia D. Tomaras, Ph.D.
Source: Health News from Medical News Today - March 21, 2014 Category: Consumer Health News Tags: HIV / AIDS Source Type: news

Targeting the C-type Lectins-Mediated Host-Pathogen Interactions with Dextran.
This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. PMID: 25224349 [PubMed - in process]
Source: J Pharm Pharm Sci - September 19, 2014 Category: Drugs & Pharmacology Authors: Pustylnikov S, Sagar D, Jain P, Khan ZK Tags: J Pharm Pharm Sci Source Type: research

Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Intranasal delivery is a simple, inexpensive and needle-free route for administration of vaccines and therapeutics. This intranasal delivery technology, developed with Creare LLC., includes low-cost, disposable drug cartridges (DDCs) that mate with a durable hand-held device. The rechargeable-battery-powered device transmits ultrasonic energy to the DDC to aerosolize the drug and is capable of performing for eight hours at 120 vaccinations per hour. Potential applications for this platform technology include intranasal vaccination (e.g. seasonal or pandemic influenza vaccines) and intranasal delivery of locally active (e.g...
Source: NIH OTT Licensing Opportunities - November 19, 2013 Category: Research Authors: admin Source Type: research

Title: The WASH Approach: Fighting Waterborne Disease in Emergency Situations
Refugees collect water from a public tap stand in an Adjumani settlement. © Wendee Nicole Rhino Camp, Arua District. Refugees in Uganda live on land donated by Ugandan nationals. Refugee families are given plots on which they can build temporary shelters and grow crops.© Wendee Nicole Oxfam staff members Tim Sutton (left) and Pius Nzuki Kitonyi (right) with the soon-to-be-repaired water pump in Adjumani. In disaster-affected situations, Oxfam takes a lead in delivering WASH-related services.© Wendee Nicole Hand-operated water pumps are a reliable source of pre...
Source: EHP Research - December 31, 2014 Category: Environmental Health Authors: Web Admin Tags: Featured Focus News Community Health Disaster Response Drinking Water Quality Infectious Disease Infrastructure International Environmental Health Microbial Agents Sanitation Warfare and Aftermath Water Pollution Source Type: research

HPV Vaccination Does Not Appear to Boost Risky Teen Sex, Study Shows
After its introduction, increase in STD rates was same in vaccinated, unvaccinated girls
Source: Fertility News - Doctors Lounge - February 9, 2015 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Family Medicine, Infections, AIDS, Pediatrics, Reproductive Medicine, News, Source Type: news

Top-Line Questions From Moms About MMR
We all want our children to be safe and healthy. Measles is a serious and highly contagious disease, but, fortunately, we can prevent it with immunizations. The measles, mumps, and rubella (MMR) vaccine is safe and the best way to protect your child against measles and other diseases. I understand that some parents are concerned about vaccines. The evidence about the vaccine's safety and benefits is strong and consistent. There is a lot of inaccurate information circulating about the measles vaccine, so let's make sure we separate the facts from the myths. If you have any concerns or questions, talk to your child's health...
Source: Healthy Living - The Huffington Post - February 28, 2015 Category: Consumer Health News Source Type: news

The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland
The objective of this study was to estimate the cost of genital warts management up to 2012 in the UK and by jurisdiction. Population statistics and the number of reported genital warts cases in genito-urinary medicine clinics were obtained and extrapolated to 2012. Cases of genital warts treated in primary care were estimated from The Health Improvement Network database. The number of visits and therapy required were estimated by genito-urinary medicine experts. Costs were obtained from the appropriate national tariffs. The model estimated there were 220,875 genital warts cases in the UK in 2012, costing £58.44 mill...
Source: International Journal of STD and AIDS - December 7, 2015 Category: Global & Universal Authors: Coles, V., Chapman, R., Lanitis, T., Carroll, S. Tags: Original research articles Source Type: research

Visceral leishmaniasis: a forgotten epidemic
Visceral leishmaniasis (VL or kala-azar) is most endemic in Asia and Africa and commonly affects young children. It is usually caused by Leishmania donovani or Leishmania infantum that are transmitted by Phlebotomine sand flies. Transmission may be anthroponotic or zoonotic or both, depending on the endemic area. Clinical features include fever, hepatosplenomegaly, weight loss and pancytopenia. Younger age, malnutrition and immunosuppression (HIV infection, use of immunosuppressive drugs) are risk factors. Many infections remain asymptomatic. Diagnosis is made by demonstration of the Leishmania parasite in aspirates of lym...
Source: Archives of Disease in Childhood - May 17, 2016 Category: Pediatrics Authors: Zijlstra, E. E. Tags: Oncology, Immunology (including allergy), ADC Global child health, HIV/AIDS, Travel medicine, Tropical medicine (infectious diseases), Child health, Sexual health Source Type: research

Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases
Conclusion: Despite the significant burden mental disorders impose on society, investment and pharmaceutical innovation in this disease area remains comparatively low. Policymakers should consider new strategies to stimulate public and private investment in the research and development of novel and effective therapies to treat schizophrenia and other mental disorders. Introduction Over the last two decades, there have been remarkable breakthroughs in healthcare. These breakthroughs include the development of novel pharmaceutical treatments that have significantly improved outcomes for patients suffering from various medica...
Source: Innovations in Clinical Neuroscience - August 1, 2016 Category: Neuroscience Authors: ICN Online Editor Tags: Bipolar Disorder Current Issue Drug Development Mental Disorders Mood Disorders Original Research Psychiatry Psychopharmacology disease burden expenditures major depressive disorder pharmaceutical innovation research and developmen Source Type: research